After being diagnosed with cancer in 2012, patient Mary Beth Zolik-Smith underwent successful chemotherapy for the non-Hodgkin lymphoma. But a few years later, her cancer returned and she had to receive treatments once again. “My perception of clinical trials at that time was they were highly experimental and not much of a guarantee,” she said, speaking…